FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074460363> ?p ?o ?g. }

• W2074460363 endingPage "69" @default.
• W2074460363 startingPage "64" @default.
• W2074460363 abstract "National Comorbidity Survey data indicate that bipolar disorder is characterized by high lifetime rates of co-occurring anxiety and substance use disorders (SUDs). Although compelling evidence suggests SUD comorbidity predicts non-response to treatment, the relationship between medical comorbidity and treatment response has not been studied adequately. In an attempt to understand the impact of medical comorbidity on treatment outcome, an analysis was conducted to inform the relationship between co-occurring medical illness, the phenomenology of bipolar disorder, and response to treatment with mood stabilizers.A total of 98 adult outpatients with rapid-cycling bipolar I or II disorder and co-occurring SUDs were prospectively treated with the combination of lithium and valproate for up to 24 weeks. A logistic regression analysis was conducted to explore the relationship between phenomenology, response to mood stabilizers, and medical comorbidity as assessed by the Cumulative Illness Rating Scale (CIRS). High and low medical comorbidity burden were defined as a CIRS total score > or = 4 and < or = 3, respectively.Every patient enrolled into this study had at least 1 medical illness (most commonly respiratory, 72%) and on average had 4.9 different medical conditions. Over half of patients (52%) exhibited illnesses across four or more different organ systems, 24% had uncontrollable medical illnesses, and the mean overall total CIRS score was 5.56. The average body mass index (BMI) was 28.1 with 38% being overweight and 29% being obese. High medical burden was observed in 64% and was most strongly predicted by a diagnosis of bipolar I disorder (OR=34.9, p=0.002, 95%CI=3.9-316.1). A history of attempted suicide (OR=10.3, p=0.01, 95%CI=1.7-62.0), a history of physical abuse (OR=7.6, p=0.03, 95%CI=1.3-45.7) and advancing age (OR=1.2, p<0.001, 95%CI=1.1-1.3) also independently predicted a high burden of general medical problems. Only 21% (N=21) of subjects enrolled into this study showed a bimodal response to treatment with lithium plus valproate, and neither BMI nor any summary CIRS measure predicted response.Rapid cycling with co-occurring substance use is not only associated with poor response to mood stabilizers, but is also a harbinger of serious medical problems. A high burden of medical comorbidity was associated with the bipolar I subtype, a history of attempted suicide, a history of physical abuse, and advancing age." @default.
• W2074460363 created "2016-06-24" @default.
• W2074460363 creator A5006575465 @default.
• W2074460363 creator A5015029664 @default.
• W2074460363 creator A5019748015 @default.
• W2074460363 creator A5020604234 @default.
• W2074460363 creator A5036716117 @default.
• W2074460363 creator A5039228625 @default.
• W2074460363 creator A5042787535 @default.
• W2074460363 creator A5063057736 @default.
• W2074460363 creator A5072267835 @default.
• W2074460363 creator A5075591850 @default.
• W2074460363 date "2009-07-01" @default.
• W2074460363 modified "2023-10-16" @default.
• W2074460363 title "Medical and substance use comorbidity in bipolar disorder" @default.
• W2074460363 cites W1906366504 @default.
• W2074460363 cites W1907155452 @default.
• W2074460363 cites W1963650892 @default.
• W2074460363 cites W1964176737 @default.
• W2074460363 cites W1969676723 @default.
• W2074460363 cites W1983522646 @default.
• W2074460363 cites W1993166557 @default.
• W2074460363 cites W1997363702 @default.
• W2074460363 cites W2006223254 @default.
• W2074460363 cites W2006745592 @default.
• W2074460363 cites W2018713883 @default.
• W2074460363 cites W2021139811 @default.
• W2074460363 cites W2033135280 @default.
• W2074460363 cites W2052484093 @default.
• W2074460363 cites W2055080279 @default.
• W2074460363 cites W2058871198 @default.
• W2074460363 cites W2061931936 @default.
• W2074460363 cites W2063678473 @default.
• W2074460363 cites W2067849939 @default.
• W2074460363 cites W2069436744 @default.
• W2074460363 cites W2073175406 @default.
• W2074460363 cites W2080350725 @default.
• W2074460363 cites W2088337626 @default.
• W2074460363 cites W2093203718 @default.
• W2074460363 cites W2093463406 @default.
• W2074460363 cites W2103308931 @default.
• W2074460363 cites W2104153167 @default.
• W2074460363 cites W2105659365 @default.
• W2074460363 cites W2113823824 @default.
• W2074460363 cites W2118471486 @default.
• W2074460363 cites W2130634903 @default.
• W2074460363 cites W2138215265 @default.
• W2074460363 cites W2145141773 @default.
• W2074460363 cites W2156493246 @default.
• W2074460363 cites W2159488624 @default.
• W2074460363 cites W2400892929 @default.
• W2074460363 doi "https://doi.org/10.1016/j.jad.2008.11.011" @default.
• W2074460363 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2866135" @default.
• W2074460363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19100627" @default.
• W2074460363 hasPublicationYear "2009" @default.
• W2074460363 type Work @default.
• W2074460363 sameAs 2074460363 @default.
• W2074460363 citedByCount "43" @default.
• W2074460363 countsByYear W20744603632012 @default.
• W2074460363 countsByYear W20744603632013 @default.
• W2074460363 countsByYear W20744603632014 @default.
• W2074460363 countsByYear W20744603632015 @default.
• W2074460363 countsByYear W20744603632016 @default.
• W2074460363 countsByYear W20744603632017 @default.
• W2074460363 countsByYear W20744603632018 @default.
• W2074460363 countsByYear W20744603632020 @default.
• W2074460363 countsByYear W20744603632021 @default.
• W2074460363 countsByYear W20744603632022 @default.
• W2074460363 countsByYear W20744603632023 @default.
• W2074460363 crossrefType "journal-article" @default.
• W2074460363 hasAuthorship W2074460363A5006575465 @default.
• W2074460363 hasAuthorship W2074460363A5015029664 @default.
• W2074460363 hasAuthorship W2074460363A5019748015 @default.
• W2074460363 hasAuthorship W2074460363A5020604234 @default.
• W2074460363 hasAuthorship W2074460363A5036716117 @default.
• W2074460363 hasAuthorship W2074460363A5039228625 @default.
• W2074460363 hasAuthorship W2074460363A5042787535 @default.
• W2074460363 hasAuthorship W2074460363A5063057736 @default.
• W2074460363 hasAuthorship W2074460363A5072267835 @default.
• W2074460363 hasAuthorship W2074460363A5075591850 @default.
• W2074460363 hasBestOaLocation W20744603632 @default.
• W2074460363 hasConcept C118552586 @default.
• W2074460363 hasConcept C15744967 @default.
• W2074460363 hasConcept C2776174506 @default.
• W2074460363 hasConcept C2779159551 @default.
• W2074460363 hasConcept C2780733359 @default.
• W2074460363 hasConcept C70410870 @default.
• W2074460363 hasConcept C71924100 @default.
• W2074460363 hasConceptScore W2074460363C118552586 @default.
• W2074460363 hasConceptScore W2074460363C15744967 @default.
• W2074460363 hasConceptScore W2074460363C2776174506 @default.
• W2074460363 hasConceptScore W2074460363C2779159551 @default.
• W2074460363 hasConceptScore W2074460363C2780733359 @default.
• W2074460363 hasConceptScore W2074460363C70410870 @default.
• W2074460363 hasConceptScore W2074460363C71924100 @default.
• W2074460363 hasIssue "1-2" @default.
• W2074460363 hasLocation W20744603631 @default.
• W2074460363 hasLocation W20744603632 @default.

• next